FDA 483 - Oregon Fertility Institute, LLC - August 18, 2021

An FDA inspection of Oregon Fertility Institute, LLC in Portland, OR, identified a deficiency in their donor screening process. The firm's questionnaire for egg donors regarding relevant communicable diseases, specifically Zika virus, did not provide adequate information on relevant risk areas. This indicates a concern with ensuring the eligibility of HCT/P donors.